![](/img/cover-not-exists.png)
Three years of treatment with once-yearly zoledronic acid influences the kinetics of bone matrix maturation in osteoporotic patients independent of bone turnover
S. Gamsjaeger, B. Buchinger, J. Gasser, E.F. Eriksen, K. Klaushofer, E.P. PaschalisVolume:
48
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bone.2011.03.098
File:
PDF, 65 KB
english, 2011